Quick answers
- What is Revlimid?
- Revlimid is a brand name of Lenalidomide, a prescription medicine. The FDA NDC Directory lists 6 Revlimid products in 6 strengths and forms.
- Who makes Revlimid?
- Bristol Myers Squibb holds the FDA application for Revlimid (NDA021880, approved December 27, 2005).
- Is there a generic or store brand of Revlimid?
- Yes. The FDA NDC Directory lists 108 other products with the same active ingredients, strength and form as a Revlimid product, 108 of them generic. Ask your pharmacist whether one is right for you.
- Has Revlimid been recalled?
- No recall linked to Revlimid products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Revlimid is
Each Revlimid product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Lenalidomide · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| lenalidomide 10 mg capsule (oral) | Revlimid | 18 products, 18 companies | DailyMed |
| lenalidomide 15 mg capsule (oral) | Revlimid | 18 products, 18 companies | DailyMed |
| lenalidomide 2.5 mg capsule (oral) | Revlimid | 18 products, 18 companies | DailyMed |
| lenalidomide 20 mg capsule (oral) | Revlimid | 18 products, 18 companies | DailyMed |
| lenalidomide 25 mg capsule (oral) | Revlimid | 18 products, 18 companies | DailyMed |
| lenalidomide 5 mg capsule (oral) | Revlimid | 18 products, 18 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Lenalidomide →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021880 | Bristol Myers Squibb | December 27, 2005 | 6 |
Companies that list Revlimid
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Revlimid products.
- Celgene Corporation6 products
Recalls
No recall linked to Revlimid products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.